News | November 11, 2024
Zydus Wellness Q2 FY25 sales up 12% at Rs. 490.7 Cr
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program
The net-zero target approval complements the company's near-term emission reduction targets
The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
At 10 years, more than one-third (34.0%) of patients with advanced melanoma were alive after treatment with KEYTRUDA, compared to 23.6% of patients treated with ipilimumab
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Objective response rate of 54.8% seen with Daiichi Sankyo and Merck’s ifinatamab deruxtecan at 12 mg/kg dose in pretreated patients
Birajeev is a seasoned Supply Chain leader with an experience of 23 years
Subscribe To Our Newsletter & Stay Updated
